Diarrhea associated with Clostridium difficile. One year retrospective study in a tertiary hospital;Diarrea asociada a Clostridium difficile. Estudio retrospectivo a un ano en un hospital terciario

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue 8, 1998, Pages 359-363

  Barreiro, Pablo M ^a,b   Pintor, Emilio ^a   Rosario Buron M ^a   Díaz, Beatriz ^a   Valverde, José ^a   De La Torre, Fernando ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE

Author keywords

Antibiotics; Clostridium difficile; Diarrhea; Pseudomembranous colitis

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG WITHDRAWAL; ELECTROIMMUNOASSAY; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; DISEASE SUSCEPTIBILITY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HIV INFECTIONS; HOSPITALS, SPECIAL; HUMANS; INCIDENCE; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; SPAIN;

EID: 0031784017     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hafiz S, Oakley CL. Clostridium difficile: isolation and characteristics. J Med Microbiol 1976; 9: 136.
2. Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobic, Bacillus difficilis. Am J Dis Child 1935; 49: 390-402.
3. Finney JMT. Gastroenterostomy for cicatrizing ulcer of the pylorus. Bulletin of Johns Hopkins Hospital 1893; 4: 53.
4. Barlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. The role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978; 75: 778-782.
5. Silva J Jr. Clostridium difficile nosocomial infections- still lethal and persistent. Infect Control Hosp Epidemiol 1994; 15: 368-370.
6. Reinke CM, Messick CR. Update in Clostridium difficile-induced colitis, part 1. Am J Hosp Pharm 1994; 51: 1.771-1.781.
7. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269: 71-75.
8. El-Mohandes AE, Keiser JF, Refat M, Jackson BJ. Prevalence and toxigenicity of Clostridium difficile isolates in fecal microflora of preterm infants in the intensive care nursery. Biol Neonate 1993; 63: 225-229.
9. Nolan NPM, Kelly CP, Humphreys JFH, Cooney C, O'Connor R, Walsh TN et al. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut 1987; 28: 1.467-1.473.
10. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81: 5-9.
11. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Eng J Med 1989; 320: 204-210.
12. Counihan TC, Roberts PL. Pseudomembranous colitis. Surg Clin North Am 1993; 73: 1.063-1.074.
13. Brown E, Talbot GM, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990; 11: 283-290.
14. Peterson LR, Kelly PJ. The role of clinical microbiology laboratory in the management of Clostridium difficile associated diarrhea. Infect Dis Clin North Am 1993; 7: 277-293.
15. Lyerly DM. The toxins of Clostridium difficile and their detection in the clinical laboratory. Clin Microbiol Updates 1992; 4: 1-4.
16. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993; 16 (Supl 4): 439-442.
17. Memoria 1995 del Hospital Clínico Universitario SanCarlos. Dep. Legal: M: 27.863, 1997; 15-18.
18. Actividad Asistencial del Hospital Clínico Universitario San Carlos. 1996; 2-4.
19. Bouza E, Padilla B, Catalán P, Sánchez-Carrillo C, Blázquez R, Peláez T. Diarrea asociada a Clostridium difficile: experiencia durante un año en un hospital General. Rev Clin Esp 1996; 196: 424-430.
20. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996; 91: 460-464.
21. Settle CD, Wilcox MH. Antibiotic-induced Clostridium difficile infection. Aliment Pharmacol Ther 1996; 10: 835-841.
22. Gerding DM, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16: 459-477.
23. Kamthan AG, Bruckner HW, Hirschman SZ, Agus SG. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med 1992; 152: 1.715-1.717.
24. Knoop FC, Owens M, Crocker IC. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 1993; 6: 251-265.
25. De Lalla F, Privitera G, Ortisi G, Rizzardini G, Santoro D, Pagano A et al. Third generation cephalosporins as a risk factor for Clostridium difficile- associated disease: a four year survey in a general hospital. J Antimicrob Chemother 1989; 23: 623-631.
26. Nelson DE, Auerbach SB, Baltch AL, Des Jardin E, Beck-Sague C, Rheal C et al. Epidemic Clostridium difficile associated diarrhea: role of second and third generation cephalosporins. Infect Control Hosp Epidemiol 1994; 15: 88-94.
27. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262.
28. Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. Arch Intern Med 1996; 156: 1.449-1.454.
29. Knobel H. Clostridium difficile. Rev Clin Esp 1996; 196: 421-423.
30. Marina M, Strong CA, Civen R, Molitoris E, Finegold SM. Bacteriology of anaerobic pleuropulmonary infections: preliminary report. CID 1993; 16 (Supl 4): 256-262.
31. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. CID 1993; 16 (Supl 4): 248-255.
32. DiPersio JR, Varga FJ, Conwell DL, Kraft JA, Kozak KJ, Willis DH. Development of rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of Clostridium difficile-associated disease. Clin Microbiol 1991; 29: 2.724-2.730.
33. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985; 80: 867-871.
34. Tedesco FJ. Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1982; 77: 220-222.
35. Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 1996; 64: 5.225-5.232.